Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Bast

Showing results (121-130 of 299) with videos related to

Pageof 30
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Anti-HER2 antibody and heregulin suppress growth of HER2-overexpressing human breast cancer cells through different mechanismsX F Le, A McWatters, J Wiener, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2000
Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase AX Fang, S X Yu, Y Lu, et al.
Obstetrics and Gynecology|September 11, 1990
Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vaginaA Berchuck, G Rodriguez, A Kamel, et al.
Leukemia Research|January 1, 1986
Antigenic heterogeneity among Burkitt's lymphoma cells surviving treatment with monoclonal antibody and complementP De Fabritiis, M Bregni, J Lipton, et al.
Obstetrics and Gynecology|February 1, 1990
Preoperative serum tumor-associated antigen levels in women with pelvic massesJ T Soper, V J Hunter, L Daly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse modelJ R Wiener, K Nakano, R P Kruzelock, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|December 1, 1994
Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cellsA Elbendary, A Berchuck, P Davis, et al.
American Journal of Obstetrics and Gynecology|March 1, 1991
Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. II. Relationship between receptor expression and response to epidermal growth factorG C Rodriguez, A Berchuck, R S Whitaker, et al.
Biochemical and Biophysical Research Communications|December 31, 1987
The early competence genes JE and KC are differentially regulated in murine peritoneal macrophages in response to lipopolysaccharideT J Koerner, T A Hamilton, M Introna, et al.
Gynecologic Oncology|October 20, 1999
Adenovirus-mediated p53 growth inhibition of ovarian cancer cells is independent of endogenous p53 statusJ K Wolf, G B Mills, L Bazzet, et al.
Pageof 30

Showing results (121-130 of 299) with videos related to

Sort By:
Pageof 30
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Anti-HER2 antibody and heregulin suppress growth of HER2-overexpressing human breast cancer cells through different mechanismsX F Le, A McWatters, J Wiener, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2000
Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase AX Fang, S X Yu, Y Lu, et al.
Obstetrics and Gynecology|September 11, 1990
Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vaginaA Berchuck, G Rodriguez, A Kamel, et al.
Leukemia Research|January 1, 1986
Antigenic heterogeneity among Burkitt's lymphoma cells surviving treatment with monoclonal antibody and complementP De Fabritiis, M Bregni, J Lipton, et al.
Obstetrics and Gynecology|February 1, 1990
Preoperative serum tumor-associated antigen levels in women with pelvic massesJ T Soper, V J Hunter, L Daly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse modelJ R Wiener, K Nakano, R P Kruzelock, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|December 1, 1994
Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cellsA Elbendary, A Berchuck, P Davis, et al.
American Journal of Obstetrics and Gynecology|March 1, 1991
Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. II. Relationship between receptor expression and response to epidermal growth factorG C Rodriguez, A Berchuck, R S Whitaker, et al.
Biochemical and Biophysical Research Communications|December 31, 1987
The early competence genes JE and KC are differentially regulated in murine peritoneal macrophages in response to lipopolysaccharideT J Koerner, T A Hamilton, M Introna, et al.
Gynecologic Oncology|October 20, 1999
Adenovirus-mediated p53 growth inhibition of ovarian cancer cells is independent of endogenous p53 statusJ K Wolf, G B Mills, L Bazzet, et al.
Pageof 30